INS and type 2 diabetes mellitus: Decreased concentrations of these enzymes in obese individuals reflect improved insulin sensitivity and reduced fat accumulation in the liver [43], whereas elevated levels represent an increased risk for the development of T2DM and CVD [44, 45].